Associations between Circulating SELENOP Level and Disorders of Glucose and Lipid Metabolism: A Meta-Analysis
Open Access
- 27 June 2022
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 11 (7) , 1263
Abstract
Selenoprotein P (SELENOP) is an extracellular antioxidant, selenium transporter, and hepatokine interfering with glucose and lipid metabolism. To study the association between the circulating SELENOP concentration and glucose and lipid metabolic diseases (GLMDs), including gestational diabetes (GD), metabolic syndrome (MetS), non-alcoholic fatty liver disease, obesity, and type 2 diabetes, as well as the individual markers, a meta-analysis was conducted by searching multiple databases from their establishment through March 2022 and including 27 articles published between October 2010 and May 2021, involving 4033 participants. Participants with GLMDs had higher levels of SELENOP than those without GLMDs (standardized mean difference = 0.84, 95% CI: 0.16 to 1.51), and the SELENOP levels were positively correlated with the markers of GLMDs (pooled effect size = 0.09, 95% CI: 0.02 to 0.15). Subgroup analyses showed that the SELENOP concentrations were higher in women with GD and lower in individuals with MetS than their counterparts, respectively. Moreover, SELENOP was positively correlated with low-density lipoprotein cholesterol, but not with the other markers of GLMDs. Thus, the heterogenicity derived from diseases or disease markers should be carefully considered while interpreting the overall positive association between SELENOP and GLMDs. Studies with a larger sample size and advanced design are warranted to confirm these findings.Keywords
Funding Information
- Science, Technology and Innovation Commission of Shenzhen Municipality, China (JCYJ20200109142446804, 81973038)
- National Natural Science Foundation of China (JCYJ20200109142446804, 81973038)
This publication has 122 references indexed in Scilit:
- The Relationship between Selenoprotein P and Glucose Metabolism in Experimental StudiesNutrients, 2013
- Selenium Supranutrition: Are the Potential Benefits of Chemoprevention Outweighed by the Promotion of Diabetes and Insulin Resistance?Nutrients, 2013
- Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic reviewBMC Public Health, 2013
- Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver DiseaseDiabetes & Metabolism Journal, 2013
- Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart StudyDiabetology & Metabolic Syndrome, 2012
- Inverse Correlation between Serum Levels of Selenoprotein P and Adiponectin in Patients with Type 2 DiabetesPLOS ONE, 2012
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Selenoprotein P—Expression, functions, and roles in mammalsBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Selenoprotein P expression is controlled through interaction of the coactivator PGC-1α with FoxO1a and hepatocyte nuclear factor 4α transcription factorsHepatology, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003